Lifestyle Change and Quality of Life in Obese Patients With Stage I/II Endometrial Cancer in Remission
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
RATIONALE: Exercise and dietary counseling may affect weight loss and improve the quality of life of obese endometrial cancer patients and may help them live longer and more comfortably.
PURPOSE: This randomized clinical trial is studying the effects of exercise and dietary counseling on weight loss and quality of life of obese patients with stage I or stage II endometrial cancer in remission.
| Condition | Intervention |
|---|---|
|
Endometrial Cancer Weight Changes |
Behavioral: behavioral dietary intervention Other: counseling intervention Other: educational intervention Other: preventative dietary intervention Procedure: quality-of-life assessment |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Intervention Model: Parallel Assignment Masking: Open Label Primary Purpose: Supportive Care |
| Official Title: | Lifestyle Change and Quality of Life in Obese Endometrial Cancer Survivors |
- Quality of life as measured by Functional Assessment of Cancer Therapy for General Cancer (FACT-G) and Functional Assessment of Cancer Therapy for Fatigue (FACT-F) at baseline, 3, 6, and 12 months [ Time Frame: baseline, 3, 6, and 12 months ] [ Designated as safety issue: No ]
- Weight loss as measured by weight, body mass index (BMI), waist circumference, Weight Efficacy Life Style Questionnaire, Three Factor Eating Inventory Questionnaire, and Leisure Score index at baseline, 3, 6, and 12 months [ Time Frame: baseline, 3, 6, and 12 months ] [ Designated as safety issue: No ]
- Functional status as measured by ECOG performance status, and short-form health survey with 36 questions (SF-36) [ Time Frame: baseline, 3, 6, and 12 months ] [ Designated as safety issue: No ]
- Comorbidities as measured by Charlson Co-Morbidity Score at baseline, 3, 6, and 12 months [ Time Frame: baseline, 3, 6, and 12 months ] [ Designated as safety issue: No ]
| Enrollment: | 47 |
| Study Start Date: | February 2005 |
| Study Completion Date: | August 2011 |
| Primary Completion Date: | January 2006 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Active Comparator: Lifestyle counseling
Patients undergo weekly contact with a dietitian; exercise intervention for 6 months; and physician counseling.Patients undergo quality of life, exercise, and clinical assessments at baseline and at 3, 6, and 12 months.
|
Behavioral: behavioral dietary intervention
Patients undergo weekly contact with a dietitian; exercise intervention for 6 months; and physician counseling at baseline and at 3, 6, and 12 months. Patients undergo quality of life assessments and clinical assessments at baseline and at 3, 6, and 12 months.
Other: counseling intervention
Patients undergo weekly contact with a dietitian; exercise intervention for 6 months; and physician counseling at baseline and at 3, 6, and 12 months. Patients undergo quality of life assessments and clinical assessments at baseline and at 3, 6, and 12 months.
Other: educational intervention
Patients undergo weekly contact with a dietitian; exercise intervention for 6 months; and physician counseling at baseline and at 3, 6, and 12 months. Patients undergo quality of life assessments and clinical assessments at baseline and at 3, 6, and 12 months.
Other: preventative dietary intervention
Patients undergo weekly contact with a dietitian; exercise intervention for 6 months; and physician counseling at baseline and at 3, 6, and 12 months. Patients undergo quality of life assessments and clinical assessments at baseline and at 3, 6, and 12 months.
Procedure: quality-of-life assessment
Patients undergo quality of life assessments and clinical assessments at baseline and at 3, 6, and 12 months.
|
|
Active Comparator: Without Counseling
Patients undergo quality of life, exercise, and clinical assessments at baseline and at 3, 6, and 12 months.
|
Procedure: quality-of-life assessment
Patients undergo quality of life assessments and clinical assessments at baseline and at 3, 6, and 12 months.
|
Detailed Description:
OBJECTIVES:
Primary
- Determine the combined effect of exercise and dietary counseling on the weight loss and quality of life of obese patients with stage I or II endometrial cancer in remission.
Secondary
- Determine the feasibility and acceptability of lifestyle interventions in these patients.
OUTLINE: This is a randomized, controlled study. Patients are stratified according to age and body mass index (25-29.9 vs ≥ 30). Patients are randomized to 1 of 2 treatment arms.
- Arm I: Patients undergo weekly contact with a dietitian; exercise intervention for 6 months; and physician counseling at baseline and at 3, 6, and 12 months. Patients undergo quality of life assessments and clinical assessments at baseline and at 3, 6, and 12 months.
- Arm II: Patients undergo quality of life, exercise, and clinical assessments at baseline and at 3, 6, and 12 months.
After completion of study treatment, patients are followed at 1 year.
PROJECTED ACCRUAL: Approximately 60 patients will be accrued for this study.
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Female |
| Accepts Healthy Volunteers: | No |
DISEASE CHARACTERISTICS:
Histologically confirmed endometrial cancer meeting the following criteria:
- Stage I or II disease
- Post-operative total abdominal hysterectomy and bilateral salpingo-oophorectomy
- Disease in remission
- Body Mass Index (BMI) ≥ 25
PATIENT CHARACTERISTICS:
Performance status
- ECOG 0-2
Life expectancy
- Not specified
Hematopoietic
- Not specified
Hepatic
- Not specified
Renal
- Not specified
PRIOR CONCURRENT THERAPY: Not specified
Contacts and Locations| United States, Ohio | |
| Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center | |
| Cleveland, Ohio, United States, 44106-5047 | |
| Principal Investigator: | Vivian von Gruenigen, MD | Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center |
More Information
Additional Information:
No publications provided by Case Comprehensive Cancer Center
Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
| Responsible Party: | Case Comprehensive Cancer Center |
| ClinicalTrials.gov Identifier: | NCT00262938 History of Changes |
| Obsolete Identifiers: | NCT00420979 |
| Other Study ID Numbers: | CASE5804, P30CA043703, CASE-5804, 02-05-05 |
| Study First Received: | December 6, 2005 |
| Last Updated: | January 17, 2012 |
| Health Authority: | United States: Federal Government |
Keywords provided by Case Comprehensive Cancer Center:
|
stage I endometrial carcinoma stage II endometrial carcinoma weight changes |
Additional relevant MeSH terms:
|
Body Weight Changes Endometrial Neoplasms Sarcoma, Endometrial Stromal Adenoma Body Weight Signs and Symptoms Uterine Neoplasms Genital Neoplasms, Female Urogenital Neoplasms Neoplasms by Site |
Neoplasms Uterine Diseases Genital Diseases, Female Neoplasms, Complex and Mixed Neoplasms by Histologic Type Sarcoma Neoplasms, Connective and Soft Tissue Endometrial Stromal Tumors Neoplasms, Glandular and Epithelial |
ClinicalTrials.gov processed this record on June 17, 2013